Literature DB >> 6619747

Compliance characteristics of 291 hypertensive patients from a rural midwest area.

R B Widmer, R J Cadoret, E Troughton.   

Abstract

Patient compliance with treatment regimens has been a concern of both researchers and clinicians. Research studies on compliance have generally originated in large city clinics and teaching institutions. The results paint a dismal picture. The question is, are the compliance percentages found in the literature applicable to the hypertensive population in the semirural Midwest who receive long-term care from their family physician? This study was carried out in the practices of seven midwestern family physicians. The 291 patients in the study had a mean compliance percentage of 87 percent. By-product data indicate that outcome results were good. Research on compliance traditionally has conceived of the problem in large part as one of defective behavior by both the patient and the health care system. The physician-patient relationship in a family practice should contribute to better medication compliance. In this study semirural patients with hypertension who receive continuing care from their family physician had better compliance than national figures suggest it should have been.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6619747

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  6 in total

Review 1.  [Reserpine-diuretic combinations in therapy of arterial hypertension. Current considerations].

Authors:  M Siepmann; W Kirch
Journal:  Med Klin (Munich)       Date:  1998-12-15

2.  A comparative assessment of the duration of action of amlodipine and nifedipine GITS in normotensive subjects.

Authors:  S Ueda; P A Meredith; C A Howie; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1993-12       Impact factor: 4.335

Review 3.  Selective versus nonselective beta adrenoceptor antagonists in hypertension.

Authors:  L M Van Bortel; A J Ament
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

Review 4.  Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?

Authors:  G J Magarian
Journal:  J Gen Intern Med       Date:  1991 Nov-Dec       Impact factor: 5.128

5.  Translating safety, efficacy and compliance into economic value for controlled release dosage forms.

Authors:  M P Cramer; S R Saks
Journal:  Pharmacoeconomics       Date:  1994-06       Impact factor: 4.981

Review 6.  Polypharmacy: the cure becomes the disease.

Authors:  C A Colley; L M Lucas
Journal:  J Gen Intern Med       Date:  1993-05       Impact factor: 5.128

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.